Episode Details
Back to Episodes
TAVNEOS Under Review by Health Canada | Montreal News
Description
Health Canada has issued a warning about TAVNEOS, a drug for a rare autoimmune condition, advising doctors to pause new prescriptions while they investigate serious concerns over the reliability of the key trial data — even prompting the New England Journal of Medicine to retract the study. Patients currently on the drug should not stop without consulting their doctor, as regulators are urgently reviewing whether the drug’s benefits outweigh its risks in Canada and are urging healthcare providers to report any adverse reactions.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/31634a49ba4779c6